Single-Cell Sequencing Screening of Biomarkers Associated with Lipophagy in the MPTP Model Mice of Parkinson's

Mei-Jun Liu1, Jing-Yi Zhu1, Shi-Yu Han1

  • 1Department of Neurology, Hospital of Chengdu university of TCM, Shier Qiao Road No.39, Chengdu, Sichuan Province, 610072, China.

PubMed

Insights

This study identifies Ubb, Gapdh, Cox4i1, and Hsp90aa1 as key biomarkers in Parkinson's disease (PD) pathogenesis. Oligodendrocytes and neurons are identified as crucial cell types involved in PD progression.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Parkinson's disease (PD) pathogenesis involves complex mechanisms, with lipophagy's role and specific molecular pathways remaining underexplored.
  • Understanding cellular and molecular changes in PD is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of lipophagy in Parkinson's disease using a mouse model.
  • To identify novel biomarkers and key cell types involved in PD pathogenesis through single-cell RNA sequencing.

Main Methods:

  • Single-cell RNA sequencing (scRNA-seq) was performed on MPTP-induced Parkinson's disease mouse models.
  • Differential gene expression analysis, cell clustering, biomarker screening using CytoNCA, and cell-cell communication analysis were employed.

Main Results:

  • scRNA-seq identified distinct cell types, including oligodendrocytes and neurons, with significant alterations in Parkinson's disease models.
  • Four genes (Ubb, Gapdh, Cox4i1, Hsp90aa1) were identified as significant biomarkers with differential expression in key cell types.
  • Biomarker expression increased at the end of oligodendrocyte and neuron differentiation, suggesting their involvement in disease progression.

Conclusions:

  • Ubb, Gapdh, Cox4i1, and Hsp90aa1 are identified as potential biomarkers for Parkinson's disease.
  • Oligodendrocytes and neurons are highlighted as critical cell types in the context of PD.
  • This research provides new theoretical insights supporting potential therapeutic strategies for Parkinson's disease.

Related Concept Videos